Harvard Bioscience Inc (HBIO)
2.84
-0.03
(-1.05%)
USD |
NASDAQ |
Jun 21, 16:00
2.82
-0.02
(-0.70%)
Pre-Market: 20:00
Harvard Bioscience Research and Development Expense (TTM): 11.75M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.75M |
| December 31, 2023 | 11.76M |
| September 30, 2023 | 11.46M |
| June 30, 2023 | 11.47M |
| March 31, 2023 | 12.01M |
| December 31, 2022 | 12.33M |
| September 30, 2022 | 12.43M |
| June 30, 2022 | 12.33M |
| March 31, 2022 | 11.53M |
| December 31, 2021 | 10.80M |
| September 30, 2021 | 10.20M |
| June 30, 2021 | 9.486M |
| March 31, 2021 | 8.682M |
| December 31, 2020 | 8.685M |
| September 30, 2020 | 8.981M |
| June 30, 2020 | 9.596M |
| March 31, 2020 | 10.47M |
| December 31, 2019 | 10.72M |
| September 30, 2019 | 11.12M |
| June 30, 2019 | 11.33M |
| March 31, 2019 | 11.32M |
| December 31, 2018 | 10.99M |
| September 30, 2018 | 9.469M |
| June 30, 2018 | 8.224M |
| March 31, 2018 | 6.762M |
| Date | Value |
|---|---|
| December 31, 2017 | 5.645M |
| September 30, 2017 | 5.275M |
| June 30, 2017 | 5.046M |
| March 31, 2017 | 5.252M |
| December 31, 2016 | 5.392M |
| September 30, 2016 | 5.768M |
| June 30, 2016 | 5.885M |
| March 31, 2016 | 6.097M |
| December 31, 2015 | 6.42M |
| September 30, 2015 | 6.452M |
| June 30, 2015 | 6.085M |
| March 31, 2015 | 5.655M |
| December 31, 2014 | 4.88M |
| September 30, 2014 | 4.434M |
| June 30, 2014 | 4.476M |
| March 31, 2014 | 4.114M |
| December 31, 2013 | 4.154M |
| September 30, 2013 | 1.831M |
| June 30, 2013 | 2.591M |
| March 31, 2013 | 3.641M |
| December 31, 2012 | 4.342M |
| September 30, 2012 | 5.473M |
| June 30, 2012 | 5.166M |
| March 31, 2012 | 4.322M |
| December 31, 2011 | 3.875M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
8.682M
Minimum
Mar 2021
12.43M
Maximum
Sep 2022
10.86M
Average
11.22M
Median
Research and Development Expense (TTM) Benchmarks
| Bruker Corp | 307.60M |
| Azenta Inc | 35.10M |
| Bionano Genomics Inc | 49.88M |
| Akoya Biosciences Inc | 21.67M |
| Singular Genomics Systems Inc | 47.03M |